MARLBOROUGH, Mass., March 30, 2026 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Asurys™ Fluid Management System, designed to provide irrigation and distention during endoscopic urologic procedures, including ureteroscopies.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/boston-scientific/9282251-en-boston-scientific-fda-clearance-asurys-fluid-management-system
Ureteroscopy is a common procedure to diagnose and treat problems in the urinary tract, most commonly kidney stones.1 Research shows that about one in 10 people will develop a kidney stone at some point in their lives.2 One challenge during ureteroscopy is maintaining fluid irrigation flow for clear visualization while keeping intrarenal pressure (IRP) low to help promote safe patient care.3-5 Elevated IRP may contribute to a range of post-operative complications including systemic inflammatory response syndrome (SIRS), sepsis and renal damage.6-10